Literature DB >> 12150791

Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons.

M Torvinen1, S Ginés, J Hillion, S Latini, M Canals, F Ciruela, F Bordoni, W Staines, F Pedata, L F Agnati, C Lluis, R Franco, S Ferré, K Fuxe.   

Abstract

The role of adenosine deaminase in the interactions between adenosine A(1) and dopamine D(1) receptors was studied in a mouse fibroblast cell line stably cotransfected with human D(1) receptor and A(1) receptor cDNAs (A(1)D(1) cells). Confocal laser microscopy analysis showed a high degree of adenosine deaminase immunoreactivity on the membrane of the A(1)D(1) cells but not of the D(1) cells (only cotransfected with human D(1) receptor cDNAs). In double immunolabelling experiments in A(1)D(1) cells and cortical neurons a marked overlap in the distribution of the A(1) receptor and adenosine deaminase immunoreactivities and of the D(1) receptor and adenosine deaminase immunoreactivities was found. Quantitative analysis of A(1)D(1) cells showed that adenosine deaminase immunoreactivity to a large extent colocalizes with A(1) and D(1) receptor immunoreactivity, respectively. The A(1) receptor agonist caused in A(1)D(1) cells and in cortical neurons coaggregation of A(1) receptors and adenosine deaminase, and of D(1) receptors and adenosine deaminase. The A(1) receptor agonist-induced aggregation was blocked by R-deoxycoformycin, an irreversible adenosine deaminase inhibitor. The competitive binding experiments with the D(1) receptor antagonist [(3)H]SCH-23390 showed that the D(1) receptors had a better fit for two binding sites for dopamine, and treatment with the A(1) receptor agonist produced a disappearance of the high-affinity site for dopamine at the D(1) receptor. R-Deoxycoformycin treatment, which has previously been shown to block the interaction between adenosine deaminase and A(1) receptors, and which is crucial for the high-affinity state of the A(1) receptor, also blocked the A(1) receptor agonist-induced loss of high-affinity D(1) receptor binding. The conclusion of the present studies is that the high-affinity state of the A(1) receptor is essential for the A(1) receptor-mediated antagonistic modulation of D(1) receptors and for the A(1) receptor-induced coaggregates of A(1) and adenosine deaminase, and of D(1) and adenosine deaminase. Thus, the confocal experiments indicate that both A(1) and D(1) receptors form agonist-regulated clusters with adenosine deaminase, where the presence of a structurally intact adenosine deaminase bound to A(1) receptors is important for the A(1)-D(1) receptor-receptor interaction at the level of the D(1) receptor recognition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150791     DOI: 10.1016/s0306-4522(02)00058-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

Review 1.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

Review 2.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

Review 3.  Partners for adenosine A1 receptors.

Authors:  Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 4.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

5.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

Review 6.  Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

Authors:  Francisco Ciruela; Víctor Fernández-Dueñas; Kenneth A Jacobson
Journal:  Neuropharmacology       Date:  2015-04-16       Impact factor: 5.250

Review 7.  Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.

Authors:  R Franco; C Lluis; E I Canela; J Mallol; L Agnati; V Casadó; F Ciruela; S Ferré; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

Review 8.  A1 Adenosine Receptor Activation Modulates Central Nervous System Development and Repair.

Authors:  Shirin Kashfi; Kamran Ghaedi; Hossein Baharvand; Mohammad Hossein Nasr-Esfahani; Mohammad Javan
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

Review 9.  Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases.

Authors:  Luigi Francesco Agnati; Sergi Ferre; Raffaella Burioni; Amina Woods; Susanna Genedani; Rafael Franco; Kjell Fuxe
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

10.  A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans.

Authors:  J V Rétey; M Adam; E Honegger; R Khatami; U F O Luhmann; H H Jung; W Berger; H-P Landolt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.